“The NEXT Frontier: THESE 3 Stocks Boom”
AI summary · TEM is not expected to profit before 2028; last quarter's net income came from about $102 million of equity gains, not operations. Its AI/data/apps segment grows 28% vs about 20% traditionally with better margins, offering hope, but he does not invest — too early to call TEM a winner in data and applications.
This is where other options such as Temps, or perhaps startups you could invest in, or Eli Lilly become very interesting. Because it's not just a company like Moderna that works in this kind of thing.